These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9191527

  • 21. Antisense RNA to eIF4E suppresses oncogenic properties of a head and neck squamous cell carcinoma cell line.
    DeFatta RJ, Nathan CO, De Benedetti A.
    Laryngoscope; 2000 Jun; 110(6):928-33. PubMed ID: 10852506
    [Abstract] [Full Text] [Related]

  • 22. TLK1B is elevated with eIF4E overexpression in breast cancer.
    Norton KS, McClusky D, Sen S, Yu H, Meschonat C, Debenedetti A, Li BD.
    J Surg Res; 2004 Jan; 116(1):98-103. PubMed ID: 14732354
    [Abstract] [Full Text] [Related]

  • 23. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
    Crew JP, Fuggle S, Bicknell R, Cranston DW, de Benedetti A, Harris AL.
    Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer.
    McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, Turnage R, McDonald JC, Abreo F, Li BD.
    Ann Surg; 2005 Oct; 242(4):584-90; discussion 590-2. PubMed ID: 16192819
    [Abstract] [Full Text] [Related]

  • 27. Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).
    Holm NT, Abreo F, Johnson LW, Li BD, Chu QD.
    Breast Cancer Res Treat; 2009 Jan; 113(2):293-9. PubMed ID: 18270814
    [Abstract] [Full Text] [Related]

  • 28. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC, DeBenedetti A.
    Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [Abstract] [Full Text] [Related]

  • 29. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas.
    Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A.
    Int J Cancer; 1995 Feb 20; 64(1):27-31. PubMed ID: 7665244
    [Abstract] [Full Text] [Related]

  • 30. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N, Takasu T, Mandai K, Nakata M, Saeki H, Heike Y, Takata I, Segawa Y, Hanafusa T, Eguchi K.
    Clin Cancer Res; 2002 Oct 20; 8(10):3046-53. PubMed ID: 12374671
    [Abstract] [Full Text] [Related]

  • 31. Modulation of translation initiation in rat skeletal muscle and liver in response to food intake.
    Yoshizawa F, Kimball SR, Jefferson LS.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):825-31. PubMed ID: 9398653
    [Abstract] [Full Text] [Related]

  • 32. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May 26; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.
    Nathan CO, Liu L, Li BD, Abreo FW, Nandy I, De Benedetti A.
    Oncogene; 1997 Jul 31; 15(5):579-84. PubMed ID: 9247311
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.
    Berkel HJ, Turbat-Herrera EA, Shi R, de Benedetti A.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 31; 10(6):663-6. PubMed ID: 11401917
    [Abstract] [Full Text] [Related]

  • 38. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.
    Breast Cancer Res Treat; 2008 Jun 31; 109(3):405-16. PubMed ID: 17687650
    [Abstract] [Full Text] [Related]

  • 39. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
    Ptushkina M, von der Haar T, Karim MM, Hughes JM, McCarthy JE.
    EMBO J; 1999 Jul 15; 18(14):4068-75. PubMed ID: 10406811
    [Abstract] [Full Text] [Related]

  • 40. Regulation of human eIF4E by 4E-BP1: binding analysis using surface plasmon resonance.
    Youtani T, Tomoo K, Ishida T, Miyoshi H, Miura K.
    IUBMB Life; 2000 Jan 15; 49(1):27-31. PubMed ID: 10772338
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.